Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Evotec Earns Boehringer Milestone | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Evotec Earns Boehringer Milestone

Oncology molecule moves into preclinical development

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Evotec AG has reached a milestone in its research alliance with Boehringer Ingelheim, triggering a payment of €4 million to Evotec. The milestone was for the transition of an oncology molecule into preclinical development.
 
Dr. Mario Polywka, chief operating officer of Evotec, said, “This is the 20th milestone achieved as part of our alliance with Boehringer Ingelheim and represents a second oncology compound transitioning into preclinical development. I would like to congratulate the teams from both companies on their continuing excellent progress in the collaboration.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics